Clinical Trial Update: Kaletra Monotherapy in HIV/HCV Co-infected Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Kaletra monotherapy in HIV/Hepatitis C co-infected subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: HIV Infections | Phase 3 | Status: COMPLETED